In the Interim…
In the Interim...
Podcast Description
A podcast on statistical science and clinical trials.
Explore the intricacies of Bayesian statistics and adaptive clinical trials. Uncover methods that push beyond conventional paradigms, ushering in data-driven insights that enhance trial outcomes while ensuring safety and efficacy. Join us as we dive into complex medical challenges and regulatory landscapes, offering innovative solutions tailored for pharma pioneers. Featuring expertise from industry leaders, each episode is crafted to provide clarity, foster debate, and challenge mainstream perspectives, ensuring you remain at the forefront of clinical trial excellence.
Podcast Insights
Content Themes
Explores Bayesian statistics, adaptive clinical trial designs, and innovative methodologies to tackle medical challenges, with episodes featuring in-depth discussions such as the transformative impact of platform trials during the COVID pandemic and regulatory navigation in adaptive trials.

A podcast on statistical science and clinical trials.
Explore the intricacies of Bayesian statistics and adaptive clinical trials. Uncover methods that push beyond conventional paradigms, ushering in data-driven insights that enhance trial outcomes while ensuring safety and efficacy. Join us as we dive into complex medical challenges and regulatory landscapes, offering innovative solutions tailored for pharma pioneers. Featuring expertise from industry leaders, each episode is crafted to provide clarity, foster debate, and challenge mainstream perspectives, ensuring you remain at the forefront of clinical trial excellence.
In this episode of “In the Interim…,” host Dr. Scott Berry examines the challenge of communicating complex statistical concepts to non-statistical audiences. Drawing from firsthand experiences in agriculture, professional golf, and clinical development, as well as examples involving historical and scientific figures, Scott reflects on why technical rigor alone often fails to influence. The discussion focuses on the consequences of mismatched language, the importance of empathy, and the utility of simulation when bridging the gap between analysis and stakeholder understanding.
Key Highlights
- Illustrated barriers to statistical communication using stories from farming, golf, and early career encounters.
- Examples involving John Glenn, Ada Lovelace, and Charles Babbage show how communication, not just science, determines impact.
- Insights from Alan Alda on empathy as a foundational tool for scientists presenting technical ideas.
- Clinical trial simulations revealed knowledge gaps—such as misunderstanding of power—when communicating with decision-makers.
- Emphasizes the necessity of translating analytic outputs into operational, financial, or clinical language for meaningful impact.
For more, visit us at https://www.berryconsultants.com/

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.